1.Study of serum LOX-1 and lipids in patients with obstructive sleep apnea hypopnea syndrome
Yan LI ; Xiuhong NIE ; Wei ZHANG ; Xiaojun FAN ; Kui REN ; Shang GAO
Chinese Journal of General Practitioners 2013;12(10):816-819
Objective To explore the changes of serum lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) and the level of lipids in patients with obstructive sleep apnea hypopnea syndrome (OSAHS).Methods A total of 94 candidates with sleep disorders between January-July 2011 at outpatient department were monitored with polysomnography.According to apnea-hypopnea index (AHI),they were divided into mild-to-moderate OSAHS (5 ≤ AHI ≤ 30) (n =27),severe OSAHS (AHI > 30) (n =37) and normal control groups (AHI < 5) (n =30).After polysomnography,their blood samples were obtained to measure the levels of serum LOX-1,triglycerides (TG),cholesterol (TC),high-density lipoprotein (HDL-C) and low-density lipoprotein (LDL-C).Results The serum level of LOX-1 in severe OSAHS group was significantly higher than that in the mild-to-moderate and control groups (P < 0.01).The serum level of LOX-1 in OSAHS patients was positively correlated with AHI and longest apnea time (LAT)(r =0.645 & 0.501 respectively,both P < 0.01) and was negatively correlated with SaO2 (r =-0.647,P <0.01).No significant difference existed in serum lipids in all groups (P > 0.05).Conclusions Intermittent hypoxia caused by OSAHS increases the level of LOX-1 to further promote the formation and development of atherosclerotic in patients with OSAHS.The levels of lipid can not effectively predict the severity of lipid metabolism disorder in patients with OSAHS.
2.Study on the anti-tumor effect of paclitaxel mixed micelle by using in vivo optical imaging technique.
Wen TAI ; Min-Min SUN ; Nan LIU ; Zhi-Qi HUANG ; Shang-Hai NIE ; Yan-Li HAO ; Xiao-Ning ZHANG
Acta Pharmaceutica Sinica 2010;45(4):530-534
In vivo tumor imaging technique method based on bioluminescence principle was established to evaluate the anti-tumor effect of paclitaxel mixed micelle (PMM). MDA-MB-231 tumor cells with luciferase reporter vectors were firstly implanted into nude mice, and subsequently the luciferase substrate was regularly injected during intraperitoneal administration of PMM. Then the tumor size, growth and the intensity of light signals were monitored with in vivo imaging technique. The method of luciferase tumor in vivo imaging could be real-time, reliable and exact in labeling and reflecting the growth of tumors, and the observed results were consistent with that by conventional method, so it would be a feasible approach to study anti-tumor effect of drugs. The anti-tumor effect of paclitaxel mixed micelle was observed by this method, and the results showed that this formulation could inhibit growth of tumor, and the anti-tumor rate of it was about 85%.
Animals
;
Antineoplastic Agents, Phytogenic
;
administration & dosage
;
pharmacology
;
therapeutic use
;
Breast Neoplasms
;
drug therapy
;
pathology
;
Cell Line, Tumor
;
Female
;
Humans
;
Luminescent Measurements
;
Male
;
Melanoma, Experimental
;
drug therapy
;
pathology
;
Mice
;
Mice, Inbred C57BL
;
Mice, Nude
;
Micelles
;
Neoplasm Transplantation
;
Paclitaxel
;
administration & dosage
;
pharmacology
;
therapeutic use
;
Particle Size
;
Tumor Burden
;
drug effects
3.Study on the expression of cytokeratin 19 mRNA in oral squamous cell carcinoma.
Yan FENG ; Ya-lan GU ; Min-hai NIE ; Qi-mei ZHANG ; Shang-zheng LIANG
West China Journal of Stomatology 2009;27(3):241-247
OBJECTIVETo elucidate the possible mechanism of oral carcinogenesis and to explore the value of clinical application of the detection of cytokeratin (CK) 19 for oral squamous cell carcinoma (OSCC) patients.
METHODSThe cancerous tissues, para-cancerous tissues and excised lymph nodes were collected from 20 operated patients with OSCC. The patients didn't receive radiotherapy and chemotherapy before hospitalization. The relative expression of CK19 mRNA in those tissues was detected by fluorescent quantitative polymerase chain reaction (FQ-PCR).
RESULTSThe expression of CK19 mRNA in the cancerous tissues was 1.85 and 1.66 times higher than that in normal oral mucosa and in para-cancerous tissues, respectively. The expression of CK19 mRNA in lymph nodes from 9 patients with OSCC was positive and the positive rate was 45% (9/20). The positive rate of CK19 mRNA in all lymph nodes from 9 patients with OSCC was 81.8% (18/22), and the positive rate of CK19 mRNA in all lymph nodes from 20 patients with OSCC was 41.9%(18/43). CK19 mRNA level in the cancerous tissues relative to para-cancerous tissues and normal oral mucosa of the patients whose CK19 mRNA expression was positive was lower than that of the patients whose CK19 mRNA expression was negative in lymph nodes, respectively.
CONCLUSIONThe possible reason that the expression of CK19 mRNA in the cancerous tissues was higher than that in para-cancerous tissues and normal oral mucosa was that the CK19 synthesis in cancerous tissues increased obviously. The detection of CK19 mRNA in lymph nodes was regarded probably as one of the markers for detecting OSCC micrometastasis in lymph nodes. The detection of CK19 mRNA in lymph nodes by FQ-PCR was more sensitive than hematoxylin-eosin staining in diagnosing OSCC micrometastasis.
Carcinoma, Squamous Cell ; Female ; Humans ; Keratin-19 ; Male ; Middle Aged ; Mouth Mucosa ; Mouth Neoplasms ; RNA, Messenger
4.Application of Microwave Drying and Sterilization Technology in TCM Field
Shuang WANG ; xia Qi NIE ; xian Bao ZHANG ; yan Li ZHANG ; Chen ZANG ; hua Guo WANG ; Yue SHANG
Chinese Journal of Information on Traditional Chinese Medicine 2017;24(11):132-136
Compared with traditional drying methods for Chinese materia medica, microwave drying technology is not only with the features of easy and convenient to operate, rapidity, good effects, well remained appearance of medicine and low energy consumption, but also with the feature of extraordinary sterilization effects at the same time with drying. This article introduced the features and effects of microwave drying and sterilization technology, reviewed its application in the TCM field, and proposed existing problems and prospects in the recent research by targeting security problems (microwave radiation and microwave residue).
5.Clinical efficacy and safety of entecavir combined with peginterferon α-2a in the treatment of chronic hepatitis B
Shang-Yan NIE ; Lei ZHAO ; Hui-Yu MA ; Huan-Huan SONG ; Min WANG ; Li-Fei LU
The Chinese Journal of Clinical Pharmacology 2015;(23):2281-2283
Objective To evaluate the clinical efficacy and safety of entecavir joint peginterferon α-2 a in the treatment of chronic hepatitis B.Methods The 80 cases of chronic hepatitis B patients were randomly divided into control group ( n =40 ) and treatment group ( n =40 ) . Patients in control group were given peginterferonα-2a 0.5 mL, once a week.Patients in treatment group were plused with oral entecavir 0.5 mg on the basis of control group, once a day.A course of treatment was a month in two groups, 12 courses of treatment. Respectively in the treatment of 3, 6, 12 months and 6 months after treatment, the hepatitis B virus ( HBV) DNA negative rate and alanine aminotransferase ( ALT) normalization rate of two groups were tested.After treatment, the clinical efficacy and incidence of adverse drug reactions of the two groups were compared.Results After treatment, the total effective rate of treatment group was significantly higher than that of control group ( 92.50% vs 67.50%, P<0.05).The treatment of 3, 6, 12 months and 6 months after treatment,the HBV DNA negative rate and ALT normalization rate of treatment group were significantly higher than those of control group (P<0.05).Adverse drug reactions in two groups had no significant difference (P>0.05).Conclusion Entecavir combined with peginterferonα-2a in the treatment of chronic hepati-tis B had distinct clinical efficacy and good safety.
6.Multicenter study on the effect of early screening skills training for autism spectrum disorders in primary care hospitals in Chengdu
Wenxu YANG ; Jiao LE ; Lan ZHANG ; Ying ZHANG ; Ping YANG ; Chunxia ZHAO ; Chunhua DU ; Junni HE ; Yanmei CAO ; Jia SHANG ; Li LI ; Yan LIU ; Shenglan WU ; Xia LI ; Xiujin CHEN ; Hai LAN ; Hua LI ; Xiang KONG ; Hengli LI ; Defang MI ; Jie ZHAO ; Yang NIE ; Jinxiu GAO ; Ling LI
Sichuan Mental Health 2022;35(4):337-342
ObjectiveTo investigate effect of conducting training of autism spectrum disorder (ASD) early screening skill on improving the ability to early identify ASD of medical staffs in primary care hospitals. MethodsIn September 2021, the training of ASD early screening skills was carried out for medical staffs from 20 primary care hospitals in Chengdu. After training, the training effect was evaluated. The numbers of referrals from primary care hospitals to superior hospitals, confirmed ASD as well as their average diagnostic age of children with ASD before and after training were used as evaluation indicators. ResultsAfter training, the number of children with suspected ASD referred by primary care hospitals was more than that before training [(16.65±11.60) vs. (3.40±2.23), t=5.431, P<0.01], the number of children diagnosed with ASD was more than that before training[(6.85±4.93) vs. (2.45±1.67), t=4.171, P<0.01], and the differences were statistically significant. As for the diagnosed age of ASD children, after training, the average age was lower than that before training [(34.95±11.67) vs. (42.2±14.64), t=-2.553, P=0.019]. ConclusionTraining of ASD early screening skills for medical staffs in primary care hospitals may help to improve their ability to early screening ASD children.